Josef D Wolf

7PUBLICATIONS
26CO-AUTHORS
Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsPharmacology and pharmaceutical sciences not elsewhere classifiedMedical virologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Antiviral GHP-88310 blocks contact-mediated and airborne transmission in a ferret model of measles-like disease.

|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

|Aug 01, 2024
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo.

Michael H J Rhodin, Archie C Reyes, Anand Balakrishnan

|Feb 08, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets.

Robert M Cox, Josef D Wolf, Nicole A Lieberman

|Aug 07, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.

Robert M Cox, Carolin M Lieber, Josef D Wolf

|Jul 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model.

Carolin M Lieber, Robert M Cox, Julien Sourimant

Pageof 2

Frequent Collaborators

7 joint publications

Richard K Plemper

5 joint publications

Zachary Sticher

4 joint publications

Robert M Cox

4 joint publications

Meghan K Smith